Humana Inc. (NYSE:HUM) Receives $222.09 Consensus PT from Brokerages

Shares of Humana Inc. (NYSE:HUM) have been given an average rating of “Hold” by the twenty-six brokerages that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and seven have given a buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $222.0870.

HUM has been the topic of a number of research reports. UBS Group reissued a “neutral” rating on shares of Humana in a report on Wednesday, February 25th. Deutsche Bank Aktiengesellschaft set a $180.00 target price on shares of Humana and gave the company a “hold” rating in a report on Friday, February 13th. Truist Financial lifted their price target on shares of Humana from $200.00 to $220.00 and gave the stock a “hold” rating in a research note on Monday, April 13th. Morgan Stanley set a $146.00 price objective on shares of Humana in a research report on Thursday, February 12th. Finally, Zacks Research lowered Humana from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 14th.

Humana Stock Up 4.0%

Humana stock opened at $223.91 on Friday. Humana has a one year low of $163.11 and a one year high of $315.35. The stock has a fifty day moving average of $185.44 and a 200 day moving average of $227.69. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00. The stock has a market cap of $26.88 billion, a PE ratio of 22.80, a price-to-earnings-growth ratio of 2.31 and a beta of 0.44.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The business’s revenue for the quarter was up 11.3% on a year-over-year basis. During the same period last year, the firm posted ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, sell-side analysts predict that Humana will post 9.05 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.6%. Humana’s dividend payout ratio is presently 36.05%.

Insider Activity at Humana

In related news, insider Sanjay K. Shetty acquired 810 shares of the firm’s stock in a transaction dated Monday, February 23rd. The shares were purchased at an average price of $185.21 per share, with a total value of $150,020.10. Following the completion of the purchase, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This represents a 7.47% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On Humana

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HUM. Montag A & Associates Inc. lifted its holdings in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC increased its stake in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the 4th quarter valued at $27,000. Reflection Asset Management bought a new stake in shares of Humana during the 4th quarter valued at $29,000. Finally, Rosenberg Matthew Hamilton lifted its stake in shares of Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after buying an additional 68 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.